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Two distinct succinate thiokinases have recently been shown to exist in animal tissues, one specific for gua- 
nine nucleotide and the other for adenine nucleotide. Their physiological roles have here been investigated 
by comparing the levels of the two enzymes in liver and brain of normal and diabetic rats. A marked rise 
in the level of brain guanine nucleotide-linked succinate thiokinase in the diabetic condition is consistent 
with an enhanced utilization of ketone bodies and hence with the associated elevated demand for succinyl- 
CoA for the activation of acetoacetate. Taken together with the reported mitochondrial values of the ATP/ 
ADP and GTP/GDP ratios, the results are interpreted to indicate that the adenine nucleotide-linked enzyme 
functions as a component of the citric acid cycle whereas the guanine nucleotide-linked enzyme functions 
in the opposite metabolic direction to produce succinyl-CoA from succinate. 
Succinate thiokinase Guanine nucleotide Diabetes Streptozotocin 
Metabolism 
Ketone body utilization (Brain) 
1. INTRODUCTION 
Succinate thiokinase (succinyl-CoA synthetase) 
(STK) catalyses the reversible reaction: 
ADP/GDP + Pi + succinyl-Coa=ATP/GTP + 
succinate + CoA-SH 
It is generally presented in textbooks of 
biochemistry that animal STKs are linked to the 
guanine nucleotides (G-STK) whereas bacterial 
and plant STKs operate with the adenine 
nucleotides (A-STK). We recently reported (11 the 
existence of distinct A-STK and G-STK enzymes in 
mammalian tissues with wide variation in the ratio 
of the two. 
* To whom correspondence should be addressed 
The presence of these two STKs poses the ques- 
tion of their physiological roles. One role for STK 
lies in the citric acid cycle, where it converts 
succinyl-CoA into succinate. In mammalian 
tissues, succinyl-CoA also plays a crucial role in 
ketone body metabolism, activating acetoacetate 
to acetoacetyl-CoA, with 3-oxoacid CoA- 
transferase (OAT). To maintain the flux of ketone 
body utilization, it is necessary to re-cycle the suc- 
cinate to succinyl-CoA (see fig. 1) again using STK. 
These different demands on the STK-catalysed 
reaction may well be accommodated by the action 
of distinct STKs. 
Ketone body meteabolism is perturbed in 
diabetes; the ability to induce diabetic 
ketoacidosis, e.g. by treatment with streptozotocin 
[2], thus offers a means of investigating the par- 
ticipation of STK. The results reported here clearly 
implicate G-STK in ketone body metabolism and, 
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as a corollary, we propose that A-STK may func- 
tion in the citric acid cycle. 
2. EXPERIMENTAL 
Female Wistar rats (180-190 g) were fed ad 
libitum. Diabetes was induced by intravenous ad- 
ministration, under anaesthesia, of streptozotocin 
(150 mg/kg body wt). After 48 h the animals were 
decapitated; blood samples were deproteinised and 
glucose concentrations determined as in [3]. Con- 
trol rats received no treatment. Tissues (groups of 
5 rats) were removed immediately and homogen- 
ized in 0.1 M Na/K phosphate buffer (pH 8.0) con- 
taining 1 mM EDTA using an Ultra-Turrax 
homogenizer (5 x 15 s bursts with cooling). After 
centrifugation (3OOOOxg for 30 min at 4°C) the 
supernatants were used without further treatment. 
STK activity was assayed as polarographically 
[4] in the presence of 0.5 mM ADP or GDP. Pro- 
tein concentrations were determined as in [5]. 
3. RESULTS AND DISCUSSION 
Blood glucose levels in the streptozotocin- 
treated rats were high (5.38 f 0.77 mg/ml) in com- 
parison with the control rats (0.61 iO.05 mg/ml). 
These elevated levels indicate the diabetic condi- 
tion of the treated rats and resemble those found 
by Schein et al. [2] who also reported a 5-fold rise 
in ketone body concentration. 
Diabetes is accompanied by enhancement of 
ketone body production by the liver and utilization 
by the brain [6,7]. We therefore examined liver and 
brain in diabetic and normal rats. Typical results 
are shown in table 1. In both tissues, A-STK activi- 
ty doubled in diabetes. In brain, this may be 
associated with increased ketone body oxidation 
via the citric acid cycle; enhanced respiration in 
liver has also been reported to accompany 
ketogenesis [8]. 
The G-STK activity of liver fell in diabetes but 
that of brain increased strikingly (5- to IO-fold in 
a series of experiments). As a consequence, the 
ratios G-STK/A-STK changed very significantly. 
Whereas in the untreated animals A-STK was the 
dominant form in brain and G-STK in liver, the 
reverse was the case in the diabetic rats (table 1). 
The ability of the brain to use ketone bodies is 
not believed to be an enzymic adaptation, as the 
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Table 1 
Effect of diabetes on the levels of succinate thiokinases 
Treatment Tissue Activity (nmol/ Ratio 
min per mg G-STK/ 
protein A-STK 
G-STK A-STK 
Control brain 0.9 1.5 0.6 
liver 4.5 1.5 3.0 
Streptozotocin brain 10.0 2.5 4.0 
liver 1.3 3.0 0.43 
enzymes responsible for ketone body metabolism 
(hydroxybutyrate dehydrogenase, 3-oxoacid CoA- 
transferase and acetoacetyl-CoA thiolase) are pre- 
sent in high activities that are unchanged by 
diabetes [9]. 
Changes in the activity of STK in diabetes have 
not previously been studied, though it has been 
suggested that the availability of succinyl-CoA 
could control ketone body utilization [ 10,111. Our 
finding that G-STK increases in brain suggests that 
it may produce the succinyl-CoA required for 
ketone body activation. Fig.1 shows the scheme 
for ketone body activation and subsequent ox- 
idative metabolism via the citric acid cycle. At two 
points succinyl-CoA is converted to succinate, by 
reaction with acetoacetate (catalysed by OAT) and 
by reaction with nucleoside diphosphate and in- 
organic phosphate (catalysed by STK). In the latter 
case, the succinate is further oxidised by the later 
steps of the citric acid cycle to reform oxaloacetate 
for condensation with the acetyl-CoA produced 
from the ketone bodies. In the former case, by 
contrast, the succinate must be reconverted to 
succinyl-CoA in order to maintain the flow of 
acetoacetate to acetoacetyl-CoA. This recycling 
could be achieved either by metabolism of suc- 
cinate round the citric acid cycle, via oxaloacetate 
and citrate, or by the action of STK operating in 
the reverse direction. 
Ottaway and co-workers [12-141 suggested that 
ketone body utilisation requires the partitioning of 
succinyl-CoA (formed by oxoglutarate dehydroge- 
nase) between OAT and STK; as the Km for 
succinyl-CoA is very much lower for STK than for 
OAT, they proposed that inhibition of STK is 
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Fig.1. Scheme of ketone body metabolism. NDP and 
NTP represent ucleoside diphosphate and triphosphate 
respectively. A and B are two points at which the suc- 
cinate thiokinase reaction occurs. 
necessary to permit ketone body activation. Such 
inhibition might be effected by maintaining a high 
NTD/NDP ratio. In support of this proposal they 
cited [14] mammalian mitochondrial values of 
ATP/ADP - 1 and GTP/GDP - 100. The pro- 
posed inhibition of STK to permit ketone body 
metabolism, when that very metabolism requires 
citric acid cycle flux, presents a difficulty, but our 
discovery of the existence of two STK enzymes, 
each specific for its nucleotide substrate, offers a 
solution. The two enzymes allow metabolic com- 
partmentation of the two distinct roles of STK. As 
part of the citric acid cycle, the A-STK can func- 
tion to phosphorylate ADP to ATP at an 
ATP/ADP ratio of - 1, while the G-STK can 
catalyse the opposite reaction (succinate to 
succinyl-CoA) at a high GTP/GDP ratio. Our 
finding that the level of G-STK in brain increases 
dramatically with increased ketone body utiliza- 
tion supports this proposal and also suggests that 
re-cycling of succinate to succinyl-CoA is indeed 
achieved directly by the action of G-STK. It is con- 
ceivable that the two STKs are differentially 
organised within the mitochondrion. 
It has been commented above that diabetes leads 
to increased ketogenesis in the liver. The reduction 
in the level of liver G-STK which we have observed 
following streptozotocin treatment may be related 
to the recent report [15] of the succinylation and 
inactivation of hydroxymethylglutaryl-CoA syn- 
thase by succinyl-CoA. This enzyme functions in 
ketone body formation; its inactivation by 
succinyl-CoA may therefore be a control 
mechanism in ketogenesis. Stimulation of 
ketogenesis, e.g. by glucagon, appears to be ac- 
companied by reduction in the concentration of 
succinyl-CoA in the liver [16]; this reduction might 
lead to de-inhibition of hydroxymethylglutaryl- 
CoA synthase and hence to increased ketogenesis 
[15]. Our observation of a decreased level of liver 
G-STK is therefore consistent with a reduction in 
succinyl-CoA formation and may be associated 
with these other processes. 
It was recently reported [17] that streptozotocin 
has a direct inhibitory action on mouse liver G- 
STK in vitro (50% inhibition at 10 nM strep- 
tozotocin), though no in vivo alteration of the ac- 
tivity of this enzyme was observed. We have tested 
the effect of 100 nM streptozotocin on rat liver and 
brain G-STK but failed to observe any inhibition. 
Hence our finding of reduced G-STK in rat liver in 
vivo following streptozotocin treatment is unlikely 
to be due to inhibition of activity but rather to a 
reduction in the level of the enzyme. 
In conclusion our results indicate that A-STK 
and G-STK play distinct metabolic roles within 
animal tissues. Moreover, as succinyl-CoA is not 
only involved in citric acid cycle and ketone body 
metabolism but also acts as a precursor of por- 
phyrins, it may be that STK performs a further 
function in providing the succinyl-CoA for that 
biosynthetic process. This is being investigated. 
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